Anti-tumor activity of naive and activated class I-restricted tumor-specific TCR-transgenic T cells.

被引：0
|
作者：
Dalyot-Herman, N [1 ]
Malek, TR [1 ]
机构：
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
来源：
FASEB JOURNAL | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A613 / A613
页数：1
相关论文
共 50 条
  • [31] The development and functions of CD4+ T cells expressing a transgenic TCR specific for an MHC-I-restricted tumor antigenic epitope
    Han, Xue
    Ye, Peiying
    Luo, Liqun
    Zheng, Linghua
    Liu, Yang
    Chen, Lieping
    Wang, Shengdian
    CELLULAR & MOLECULAR IMMUNOLOGY, 2011, 8 (04) : 333 - 340
  • [32] In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells
    Kass, R
    Agha, J
    Bellone, S
    Palmieri, M
    Canè, S
    Bignotti, E
    Henry-Tillman, R
    Hutchins, L
    Cannon, MJ
    Klimberg, S
    Santin, AD
    JOURNAL OF SURGICAL RESEARCH, 2003, 112 (02) : 189 - 197
  • [33] MODULATION OF CELLULAR ANTI-TUMOR RESPONSES BY TUMOR-SPECIFIC T-SUPPRESSOR LYMPHOCYTE-TS
    HAUBECK, HD
    STUTENKEMPER, R
    KOLSCH, E
    IMMUNOBIOLOGY, 1988, 178 (1-2) : 77 - 78
  • [34] A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection
    Morris, EC
    Tsallios, A
    Bendle, GM
    Xue, SA
    Stauss, HJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (22) : 7934 - 7939
  • [35] Ex vivo anti-tumor activity of rosiglitazone on multiple myeloma cells.
    Huang, Haiwen
    Wu, De Pei
    Leung, Anskar Y. H.
    Liang, Raymond
    Lie, Albert K. W.
    BLOOD, 2006, 108 (11) : 352B - 352B
  • [36] ANTI-TUMOR IN VIVO EFFICACY OF T CELLS TRANSDUCED WITH MAGE-A4-SPECIFIC αβ TYPE TCR GENES
    Ikeda, Hiroaki
    Shirakura, Yoshitaka
    Hirayama, Michiko
    Hiasa, Atsunori
    Nishikawa, Hiroyoshi
    Kitano, Shigehisa
    Tajima, Kazuo
    Nukaya, Ikuei
    Yu, Shen Sin
    Mineno, Junichi
    Ito, Mamoru
    Kato, Ikunoshin
    Shiku, Hiroshi
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1163 - 1163
  • [37] Inducible MyD88/CD40 (iMC) Enhances Proliferation and Survival of Tumor-Specific TCR-Modified T Cells and Improves Anti-Tumor Efficacy in Myeloma
    Pentcheva-Hoang, Tsvetelina
    Torres, David
    Rodriguez, Tania
    Korngold, Ana
    Lu, An
    Crisostomo, Jeannette
    Moseley, Annemarie
    Jahn, Lorenz
    Heemskerk, Mirjam H. M.
    Slawin, Kevin M.
    Spencer, David M.
    Foster, Aaron E.
    BLOOD, 2016, 128 (22)
  • [38] HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer
    Hoshino, T
    Seki, N
    Kikuchi, M
    Kuramoto, T
    Iwamoto, O
    Kodama, I
    Koufuji, K
    Takeda, J
    Itoh, K
    INTERNATIONAL JOURNAL OF CANCER, 1997, 70 (06) : 631 - 638
  • [39] Induction of Potent Anti-Tumor Effects by Original and TCR-Redirected CD4 + Cytotoxic T Cells.
    Spaapen, Robbert M.
    van den Oudenalder, Kelly
    van Elk, Maureen
    Aarts, Tineke
    Guichelaar, Teun
    Groen, Richard W. J.
    Bloem, Andries C.
    Storm, Gert
    Martens, Anton C.
    Lokhorst, Henk M.
    Mutis, Tuna
    BLOOD, 2009, 114 (22) : 545 - 545
  • [40] Dendritic cells regulate tumor-homing potential and tumoricidal activity of tumor-specific T cells
    Watchmaker, Payal
    Muthuswamy, Ravikumar
    Urban, Julie
    Kirkwood, John M.
    Bartlett, David
    Kalinski, Pawel
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 904 - 904
12345